Literature DB >> 26331573

Short Communication: Low False Recent Rate of Limiting-Antigen Avidity Assay Among Long-Term Infected Subjects from Guangxi, China.

Li Yu1, Oliver Laeyendecker2,3, Sarah K Wendel2, Fuxiong Liang1, Wei Liu1, Xueyan Wang1, Lu Wang1, Xianwu Pang1, Zhongliao Fang1.   

Abstract

Assays used for HIV cross-sectional incidence testing can misclassify some individuals with nonrecent HIV infection as recently infected, overestimating HIV incidence. We analyzed the frequency and factors associated with false-recent misclassification on subjects from Quangxi, China known to have long-term infection using the limited antigen-avidity assay (LAg-Avidity). Stored samples from treatment-naive individuals from Guangxi, China were tested using the LAg-Avidity. A total of 362 samples from individuals known to be infected 2 to 13.5 years were tested and the false-recent rate (FRR), the frequency of samples with a positive result, was determined at different cutoff values of the assay. Additionally, factors associated with misclassification were determined. The FRR of the LAg-Avidity was 1.1% (4/362) using a cutoff of 1.5 normalized optical density units (OD-n). All four samples had viral loads >1,000 copies/ml. Using a cutoff of 3.0 OD-n the FRR was 5.5% (20/362), with four samples having viral loads <1,000 copies/ml. Factors associated with a higher odds of misclassification were female gender (OR 7.7, 95% CI 1.0-56.4) and being a female sex worker (OR 31.3, 95% CI 4.0-242). At the higher cutoff, being of Zhuang decent, relative to Han, had higher odds of misclassification (OR 6.2, 95% CI 1.99-19.0). The LAg-Avidity assay had a low FRR in this Chinese population. Further investigations of the higher frequency of low LAg-Avidity results seen in female sex workers and individuals of Zhuang descent should be explored in a larger study.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26331573      PMCID: PMC4663635          DOI: 10.1089/aid.2015.0097

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  9 in total

1.  Correlation of prospective and cross-sectional measures of HIV type 1 incidence in a higher-risk cohort in Ho Chi Minh City, Vietnam.

Authors:  Connie J Sexton; Elizabeth C Costenbader; Dang Thi Nhat Vinh; Pai Lien Chen; Tran Vu Hoang; Nguyen Thi Hoang Lan; Paul Feldblum; Andrea Kim; Le Truong Giang
Journal:  AIDS Res Hum Retroviruses       Date:  2011-11-09       Impact factor: 2.205

2.  A serial risk score approach to disease classification that accounts for accuracy and cost.

Authors:  Dat Huynh; Oliver Laeyendecker; Ron Brookmeyer
Journal:  Biometrics       Date:  2014-08-25       Impact factor: 2.571

3.  Prevalence of transmitted HIV-1 drug resistance remains low in Guangxi, China, eight years after scale-up of highly-active antiretroviral therapy.

Authors:  Guojian Li; Shujia Liang; Tim J Harrison; Zhenzhu Tang; Zhiyong Shen; Xueyan Wang; Xinghua Wu; Wei Liu; Fuxiong Liang; Liushuai Feng; Jinye Yang; Zhongliao Fang
Journal:  Intervirology       Date:  2014-06-28       Impact factor: 1.763

4.  Estimating HIV Incidence in Populations Using Tests for Recent Infection: Issues, Challenges and the Way Forward.

Authors:  Timothy D Mastro; Andrea A Kim; Timothy Hallett; Thomas Rehle; Alex Welte; Oliver Laeyendecker; Tom Oluoch; Jesus M Garcia-Calleja
Journal:  J HIV AIDS Surveill Epidemiol       Date:  2010-01-01

5.  Detection of recent HIV-1 infection using a new limiting-antigen avidity assay: potential for HIV-1 incidence estimates and avidity maturation studies.

Authors:  Yen T Duong; Maofeng Qiu; Anindya K De; Keisha Jackson; Trudy Dobbs; Andrea A Kim; John N Nkengasong; Bharat S Parekh
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

6.  More and better information to tackle HIV epidemics: towards improved HIV incidence assays.

Authors: 
Journal:  PLoS Med       Date:  2011-06-14       Impact factor: 11.069

7.  Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes.

Authors:  Yen T Duong; Reshma Kassanjee; Alex Welte; Meade Morgan; Anindya De; Trudy Dobbs; Erin Rottinghaus; John Nkengasong; Marcel E Curlin; Chonticha Kittinunvorakoon; Boonyos Raengsakulrach; Michael Martin; Kachit Choopanya; Suphak Vanichseni; Yan Jiang; Maofeng Qiu; Haiying Yu; Yan Hao; Neha Shah; Linh-Vi Le; Andrea A Kim; Tuan Anh Nguyen; William Ampofo; Bharat S Parekh
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

8.  Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository.

Authors:  Reshma Kassanjee; Christopher D Pilcher; Sheila M Keating; Shelley N Facente; Elaine McKinney; Matthew A Price; Jeffrey N Martin; Susan Little; Frederick M Hecht; Esper G Kallas; Alex Welte; Michael P Busch; Gary Murphy
Journal:  AIDS       Date:  2014-10-23       Impact factor: 4.177

9.  Different distribution of HIV-1 subtype and drug resistance were found among treatment naïve individuals in Henan, Guangxi, and Yunnan province of China.

Authors:  Lin Li; Guoqing Sun; Shujia Liang; Jianjian Li; Tianyi Li; Zhe Wang; Wei Liu; Shaomin Yang; Yongjian Liu; Xiaolin Wang; Jingyun Li
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

  9 in total
  5 in total

1.  Estimating False-Recent Classification for the Limiting-Antigen Avidity EIA and BED-Capture Enzyme Immunoassay in Vietnam: Implications for HIV-1 Incidence Estimates.

Authors:  Neha S Shah; Yen T Duong; Linh-Vi Le; Nguyen Anh Tuan; Bharat S Parekh; Hoang Thi Thanh Ha; Quang Duy Pham; Cao Thi Thu Cuc; Trudy Dobbs; Tran Hong Tram; Truong Thi Xuan Lien; Nick Wagar; Chunfu Yang; Amy Martin; Mitchell Wolfe; Nguyen Tran Hien; Andrea A Kim
Journal:  AIDS Res Hum Retroviruses       Date:  2017-03-13       Impact factor: 2.205

2.  Analysis of Viral Diversity in Relation to the Recency of HIV-1C Infection in Botswana.

Authors:  Sikhulile Moyo; Alain Vandormael; Eduan Wilkinson; Susan Engelbrecht; Simani Gaseitsiwe; Kenanao P Kotokwe; Rosemary Musonda; Frank Tanser; Max Essex; Vladimir Novitsky; Tulio de Oliveira
Journal:  PLoS One       Date:  2016-08-23       Impact factor: 3.240

3.  Decision tree for accurate infection timing in individuals newly diagnosed with HIV-1 infection.

Authors:  Chris Verhofstede; Katrien Fransen; Annelies Van Den Heuvel; Kristel Van Laethem; Jean Ruelle; Ellen Vancutsem; Karolien Stoffels; Sigi Van den Wijngaert; Marie-Luce Delforge; Dolores Vaira; Laura Hebberecht; Marlies Schauvliege; Virginie Mortier; Kenny Dauwe; Steven Callens
Journal:  BMC Infect Dis       Date:  2017-11-29       Impact factor: 3.090

4.  Pairwise diversity and tMRCA as potential markers for HIV infection recency.

Authors:  Sikhulile Moyo; Eduan Wilkinson; Alain Vandormael; Rui Wang; Jia Weng; Kenanao P Kotokwe; Simani Gaseitsiwe; Rosemary Musonda; Joseph Makhema; Max Essex; Susan Engelbrecht; Tulio de Oliveira; Vladimir Novitsky
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

Review 5.  Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review.

Authors:  Shelley N Facente; Eduard Grebe; Andrew D Maher; Douglas Fox; Susan Scheer; Mary Mahy; Shona Dalal; David Lowrance; Kimberly Marsh
Journal:  JMIR Public Health Surveill       Date:  2022-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.